BENIGN HEMATOLOGY PROGRAM

Anemia Clinical Research

1. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, Khreiss M, Dahdaleh FS, Khavandi K, Sfeir PM, Soweid A, Hoballah JJ, Taher AT, Jamali FR. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011 Oct 15;378(9800):1396-407. doi: 10.1016/S0140-6736(11)61381-0. Epub 2011 Oct 5. PMID: 21982521.

2. Iolascon A, Rivella S, Anagnou NP, Camaschella C, Swinkels D, Muckenthaler MU, Porto G, Barcellini W, Andolfo I, Risitano AM, Kattamis A, Cappellini MD, Taher AT, De Franceschi L, Rees D, Russo R, Tamary H, Stauder R, Girelli D. The EHA Research Roadmap: Anemias. Hemasphere. 2021 Jun 30;5(7):e607. doi: 10.1097/HS9.0000000000000607. Erratum in: Hemasphere. 2021 Sep 30;5(10):e649. PMID: 34522846; PMCID: PMC8432644.

3. Baydoun A, Maakaron JE, Halawi H, Abou Rahal J, Taher AT. Hematological manifestations of celiac disease. Scand J Gastroenterol. 2012 Dec;47(12):1401-11. doi: 10.3109/00365521.2012.706828. Epub 2012 Aug 6. PMID: 22861356.

4. Moukalled NM, El Rassi FA, Temraz SN, Taher AT. Iron overload in patients with myelodysplastic syndromes: An updated overview. Cancer. 2018 Oct 15;124(20):3979-3989. doi: 10.1002/cncr.31550. Epub 2018 Jun 15. PMID: 29905937.

5. Temraz S, Santini V, Musallam K, Taher A. Iron overload and chelation therapy in myelodysplastic syndromes. Crit Rev Oncol Hematol. 2014 Jul;91(1):64-73. doi: 10.1016/j.critrevonc.2014.01.006. Epub 2014 Jan 24. PMID: 24529413.

6. Jabbour E, Garcia-Manero G, Taher A, Kantarjian HM. Managing iron overload in patients with myelodysplastic syndromes with oral deferasirox therapy. Oncologist. 2009 May;14(5):489-96. doi: 10.1634/theoncologist.2008-0154. Epub 2009 Apr 13. PMID: 19365094.

7. Jabbour E, Kantarjian HM, Koller C, Taher A. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes. Cancer. 2008 Mar 1;112(5):1089-95. doi: 10.1002/cncr.23280. PMID: 18186499.

8. Taher AT, Musallam KM, Nasreddine W, Perrine SP, El-Hajj TI, Beydoun A. Effects of divalproex sodium on hemoglobin level. Blood Cells Mol Dis. 2009 Jul-Aug;43(1):49-52. doi: 10.1016/j.bcmd.2009.01.015. Epub 2009 Mar 1. PMID: 19254854.

9. Tyan P, Taher A, Carey E, Sparks A, Radwan A, Amdur R, Tamim H, Gu A, Robinson H, Moawad GN. The effect of anemia severity on postoperative morbidity among patients undergoing laparoscopic hysterectomy for benign indications. Acta Obstet Gynecol Scand. 2020 Jan;99(1):112-118. doi: 10.1111/aogs.13718. Epub 2019 Oct 11. PMID: 31449328.

10. Jabr FI, Aoun E, Azar C, Taher A. Diamond-Blackfan anemia responding to valproic acid. Blood. 2004 Nov 15;104(10):3415. doi: 10.1182/blood-2004-06-2444. PMID: 15525842.

11. Otrock ZK, Chamseddine N, Salem ZM, Wehbe T, Al-Ayoubi M, Dhaini M, Kattan J, Mokaddem W, Nasr TA, Jradi O, Farhat FS, Wehbe M, Haidar MH, Kharfan-Dabaja MA, Bitar N, Hajj ME, Kadri AM, Kamar FG, Yassine H, Khodr H, Taher AT, Hakime N, Mahfouz RA, Serhal W, Bazarbachi A, Farhat HZ. A nationwide non-interventional epidemiological data registry on myelodysplastic syndromes in Lebanon. Am J Blood Res. 2015 Dec 25;5(2):86-90. PMID: 27069756; PMCID: PMC4769350.

12. Taher AT, Musallam KM, Koussa S, Inati A. Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy. Ann Hematol. 2009 Dec;88(12):1263-4. doi: 10.1007/s00277-009-0750-6. Epub 2009 May 5. PMID: 19415275.

13. Ahmed MR, Chehal A, Zahed L, Taher A, Haidar J, Shamseddine A, O’Hea AM, Bienz N, Dgany O, Avidan N, Beckmann JS, Tamary H, Higgs D, Vyas P, Wood WG, Wickramasinghe SN. Linkage and mutational analysis of the CDAN1 gene reveals genetic heterogeneity in congenital dyserythropoietic anemia type I. Blood. 2006 Jun 15;107(12):4968-9. doi: 10.1182/blood-2006-01-0081. PMID: 16754775.

14. Jabr FI, Taher A. Diamond-Blackfan anemia in remission for 2 years on valproic acid. Haematologica. 2006 Jun;91(6 Suppl):ELT05. PMID: 16785135.